LC
MED icon

Lindbrook Capital’s Medifast MED Stock Holding History

Lindbrook Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69
Closed -$2.64K – 2814
2024
Q1 		$2.64K Buy
69
+46
+200% +$2.23K ﹤0.01% 2143
2023
Q4 		$1.55K Sell
23
-27
-54% -$1.88K ﹤0.01% 2352
2023
Q3 		$3.74K Sell
50
-58
-54% -$5.15K ﹤0.01% 1900
2023
Q2 		$9.95K Buy
108
+90
+500% +$8.01K ﹤0.01% 1471
2023
Q1 		$1.87K Buy
18
+2
+13% +$222 ﹤0.01% 2276
2022
Q4 		$1.85K Sell
16
-54
-77% -$6.29K ﹤0.01% 2263
2022
Q3 		$8K Buy
70
+51
+268% +$7.31K ﹤0.01% 1439
2022
Q2 		$3K Buy
19
+4
+27% +$716 ﹤0.01% 1803
2022
Q1 		$3K Sell
15
-13
-46% -$2.45K ﹤0.01% 1842
2021
Q4 		$6K Hold
28
– – ﹤0.01% 1447
2021
Q3 		$5K Hold
28
– – ﹤0.01% 1246
2021
Q2 		$8K Hold
28
– – ﹤0.01% 1141
2021
Q1 		$6K Hold
28
– – ﹤0.01% 1213
2020
Q4 		$5K Hold
28
– – ﹤0.01% 1195
2020
Q3 		$5K Hold
28
– – ﹤0.01% 1115
2020
Q2 		$4K Hold
28
– – ﹤0.01% 1181
2020
Q1 		$2K Sell
28
-6
-18% -$546 ﹤0.01% 1307
2019
Q4 		$4K Hold
34
– – ﹤0.01% 1155
2019
Q3 		$4K Hold
34
– – ﹤0.01% 1110
2019
Q2 		$4K Hold
34
– – ﹤0.01% 1106
2019
Q1 		$4K Hold
34
– – ﹤0.01% 1123
2018
Q4 		$4K Buy
+34
New +$5.82K ﹤0.01% 1069

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lindbrook Capital's MED Position: Q2 2024 in Review

Lindbrook Capital sold out of Medifast (MED) in Q2 2024, closing a stake of 69 shares — an estimated $2.64K sold.

Lindbrook Capital first reported a position in MED in Q4 2018 and held it in 22 quarters. The position peaked at $9.95K in Q2 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Lindbrook Capital reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Lindbrook Capital sold 69 Medifast shares in Q2 2024, an estimated $2.64K.
  • Lindbrook Capital first reported a position in Medifast in Q4 2018 and held it in 22 quarters.
  • Lindbrook Capital's Medifast position peaked at $9.95K in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.